Congrats to @KrcRebecca for publishing the @MarylandProton data supporting proton re-RT for recurrent H&N cancer with genomic data to drive personalized care.
authors.elsevier.com/c/1jBcv4tFDINv…
@RaneeMehra @UMarylandRadOnc #hncs @UMGCCC
English
Matthew Witek, MD, MS
204 posts
Matthew Witek, MD, MS
@MatthewWitekMD
Director CNS Rad Onc | Assoc Prof Rad Onc @Georgetown @MedStarGUH | CNS Ca | Head & Neck Ca | Skin Ca | | @LombardiCancer | 🎹 |🐧 🏒
Washington, D.C. Katılım Eylül 2016
213 Takip Edilen158 Takipçiler
Matthew Witek, MD, MS retweetledi
#hncs congratulations to Dr @MatthewWitekMD and colleagues at university of Maryland for accomplishing a trial of rational contralateral volume reduction in oropharyngeal cancer. Cutting dose to organs at risk without contralateral failures in a relatively high risk cohort
English
Matthew Witek, MD, MS retweetledi
Great presentation by Jason Molitoris discussing results of our Saver trial Contralateral de-escalation of p16+ OPC #HNCS24 @UMGCCC @MatthewWitekMD @HattenMD @UMarylandRadOnc
English
Matthew Witek, MD, MS retweetledi
Big news for low risk HPV+ oropharyngeal cancer de-escalation. 60+cis did not meet non-inferiority threshold.
NRG Oncology@NRGonc
NRG-HN005 results of scheduled interim futility analysis comparing experimental arm to control arm for randomized phase II portion of the study showed that the experimental arm didn't achieve non-inferiority threshold per statistical analysis plan. conta.cc/3DRvsu2
English
Matthew Witek, MD, MS retweetledi
We welcome the newest physician to our team!
Dr. Gregory Alexander from the Univ of Maryland.
@KimmelCancerCtr @JeffersonUniv @TJUHospital @JeffRadOnc
English
Matthew Witek, MD, MS retweetledi
MSKCC @imrtlee reports that protons (IMPT) are less toxic than IMRT for patients with OPC cancer - confirms findings from Mayo @MayoClinic and MDACC @MDAndersonNews
bit.ly/3hDPcsX
English
Dr. Rodrigues and Dr. Molitoris at @MPTC are working on a new project “Image-guided #hyperthermia for the treatment of tumors.” Looking forward to reviewing the results.
English
Hodgkins Lymphoma survivors may have a higher risk of developing secondary lung cancer. #LungCancer
cancertherapyadvisor.com/home/cancer-to…
English
Matthew Witek, MD, MS retweetledi
Resident Dr. Bansi Savla @savlabansi will present The Impact of BMI and Residence in Food Priority Areas on Patterns-of-Care & Cancer Outcomes in Patients with Stage III #NSCLC 10/23, 4:45 PM, ex hall 1 at #ASTRO22. #healthdisparities #healthequity @PranshuMohindra @dr_dominica
English
Matthew Witek, MD, MS retweetledi
Matthew Witek, MD, MS retweetledi
Congratulations to Dr. William Regine and Dr. Mark Mishra @MarkMishraMD on being recognized as 2022 "Top Docs" by @Baltimoremag as they support our missions of patient care, research, education & outreach through passionate patient-centered care. ow.ly/HSZu50Levp4
University of Maryland Medical System@umms
Congratulations to our providers across the System for being recognized as Top Doctors by @Baltimoremag. These providers were recognized as the best in the region. Your care and dedication help ensure a better state of care for our patients. Learn more: ow.ly/HSZu50Levp4
English
Researchers discovered a new way to diagnose prostate cancer sooner. Earlier diagnosis means better outcomes for patients. #ProstateCancer#CancerDiagnosis
sciencedaily.com/releases/2022/…
English
Interesting read on HPV-related throat cancer and how the outcome in men varies by race and ethnicity. #ThroatCancer
physiciansweekly.com/hpv-related-th…
English
Matthew Witek, MD, MS retweetledi
Matthew Witek, MD, MS retweetledi
New UMB Center for Violence Prevention announced live next week. CMRO Rad Onc employee Liza Holley lost her 33-year-old son Daurell L. Hudson to gun violence & will speak at news conference on intervention & prevention. Livestream @UMBaltimore Sept. 6 at 12 pm ET. @shocktrauma
English
Matthew Witek, MD, MS retweetledi
UM Vice Chairs for Research Dr. Phuoc Tran (left) and Med Physics Dr. @realAmitSawant (right), and Dr. @NickieSimone4 (Thomas Jefferson) will receive a 5 yr grant for >$7.5 million to co-lead the ROBIN OligoMET Center for primary and metastatic disease response to radiation
English
Check out the finding from a recent #clinicaltrial I worked on that focused on oropharynx cancer:
pubmed.ncbi.nlm.nih.gov/35446279/
English